For example, 144 up-regulated phosphoproteins in plasma sEVs of BC patients were identified by LC–MS/MS and phosphorylation of RALGAPA2, PKG1, and TJP2 were validated by PRM, therefore these phosphoproteins are candidate sEV biomarkers for BC diagnosis [145]. This evidence concerns the gene RALGAPA2 and breast cancer.